Physician

Ladd Clayton Atkins, D.O.

According to 2025 Medicare claims, Ladd Atkins, D.O. (NPI: 1912198375) practices general surgery in the Fort Smith, AR-OK market, with the plurality of this provider's patient population coming from Sequoyah, OK. This provider's primary affiliated billing organization is REVELATION MEDICAL OF TULSA LLC (NPI: 1366194110; TIN: 873758204) and primary practice location at 74135-2908.

Atkins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 1,023 HCPCS/CPT codes, and received $144,830 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 5,411 prescription claims across 713 beneficiaries totaling $271,454 in drug costs, led by Mounjaro (Tirzepatide). 2020 DME data shows 11 claims. Open Payments data shows 12 records totaling $423. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $39,916 and ending at $144,830. Concurrently, Part D prescription costs have fallen sharply in recent years, from $18,586 to $271,454. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	39	933	$39,916
2016	30	140	$9,997
2017	317	1,458	$102,690
2018	490	2,089	$145,473
2019	481	3,487	$225,376
2020	366	2,693	$157,106
2021	208	1,784	$77,496
2022	183	1,849	$184,984
2023	207	1,344	$144,657
2024	227	1,023	$144,830

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	106	$18,586
2016	26	90	$8,841
2017	410	2,210	$209,120
2018	618	6,554	$588,604
2019	634	7,027	$533,654
2020	604	8,554	$470,105
2021	548	4,577	$276,688
2022	128	803	$28,650
2023	323	2,225	$140,908
2024	713	5,411	$271,454

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$476
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	70	73	$242
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	45	45	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	72	77	$94
80307	Testing for presence of drug, by chemistry analyzers	71	75	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	98	425	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	62	1,904	$65,526
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,768	50,032	$57,955
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	727	20,221	$23,560
Belbuca	Buprenorphine Hcl	32	937	$21,738
Oxycodone Hcl	Oxycodone Hcl	845	23,982	$15,040

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$423	Next Science LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ladd Clayton Atkins, D.O.?

Tedicare shows public-source Medicare data for Ladd Clayton Atkins, D.O. (NPI 1912198375), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ladd Clayton Atkins, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ladd Clayton Atkins, D.O.?

Ladd Clayton Atkins, D.O. is linked to REVELATION MEDICAL OF TULSA LLC (billing NPI 1366194110) in the available physician profile data.

Does Ladd Clayton Atkins, D.O. have Open Payments data?

Ladd Clayton Atkins, D.O. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.